Symposium overview: estrogens and antiestrogens in managing the patient with breast cancer. Conference Paper uri icon

Overview

abstract

  • The prevalence of breast cancer (a hormonally driven neoplasm) in the United States, the potential health benefits of estrogen replacement therapy for postmenopausal women, and the burgeoning research focusing on selective estrogen receptor modulators (SERMs) have resulted in additional complexity in managing breast cancer. In an attempt to clarify existing data, the Society of Surgical Oncology sponsored a symposium entitled "Estrogens and Antiestrogens in Managing the Patient with Breast Cancer" at its 52nd Annual Cancer Symposium. This conference was held in March 1999 and was chaired by Dr. S. Eva Singletary, Professor of Surgery and Chief of the Surgical Breast Section at The University of Texas M. D. Anderson Cancer Center in Houston, Texas. The following is a review of the material presented by the symposium participants.

publication date

  • September 1, 2000

Research

keywords

  • Breast Neoplasms
  • Estrogen Receptor Modulators
  • Estrogen Replacement Therapy

Identity

Scopus Document Identifier

  • 0033834990

Digital Object Identifier (DOI)

  • 10.1007/BF02725335

PubMed ID

  • 11005554

Additional Document Info

volume

  • 7

issue

  • 8